Avidity Biosciences Inc (NASDAQ: RNA)’s stock price has gone decline by -0.70 in comparison to its previous close of 23.55, however, the company has experienced
RNA has 36-month beta value of 0.77. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,”
The stock of Avidity Biosciences Inc (RNA) has seen a -3.97% decrease in the past week, with a 23.77% gain in the past month, and
The stock of Avidity Biosciences Inc (RNA) has seen a 3.03% increase in the past week, with a 63.13% gain in the past month, and
Avidity Biosciences Inc (NASDAQ: RNA) has experienced a rise in its stock price by 1.89 compared to its previous closing price of 23.79. However, the
© 2024, Fueled by Smart TechOne
